158 related articles for article (PubMed ID: 15223014)
1. Ceramides and glycosphingolipids in maturation process: leukemic cells as an experimental model.
Smoleńska-Sym G; Spychalska J; Zdebska E; Woźniak J; Traczyk Z; Pszenna E; Maj S; Danikiewicz W; Bieńkowski T; Kościelak J
Blood Cells Mol Dis; 2004; 33(1):68-76. PubMed ID: 15223014
[TBL] [Abstract][Full Text] [Related]
2. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
3. Alteration in glycosphingolipid pattern during phorbol-12-myristate-13-acetate-induced cell differentiation in human T-lymphoid leukemia cells.
Kiguchi K; Henning-Chubb C; Huberman E
Cancer Res; 1986 Jun; 46(6):3027-33. PubMed ID: 3486042
[TBL] [Abstract][Full Text] [Related]
4. Analysis of neutral glycosphingolipids from Trypanosoma brucei.
Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
Vet Parasitol; 2006 Sep; 140(3-4):264-72. PubMed ID: 16806714
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside shedding and changes in ceramide biosynthesis in human ovarian tumors.
Dyatlovitskaya EV; Andreasyan GO; Malykh YaN ; Rylova SN; Somova OG
Biochemistry (Mosc); 1997 May; 62(5):557-61. PubMed ID: 9275295
[TBL] [Abstract][Full Text] [Related]
6. Glycosphingolipid structural analysis and glycosphingolipidomics.
Levery SB
Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
[TBL] [Abstract][Full Text] [Related]
7. Identification of GM3 as a marker of therapy-resistant periradicular lesions.
Zuolo ML; Toledo MS; Nogueira HE; Straus AH; Takahashi HK
J Endod; 2001 Feb; 27(2):107-9. PubMed ID: 11491632
[TBL] [Abstract][Full Text] [Related]
8. Changes in glycosphingolipids accompanying the differentiation of human squamous SQCC/Y1 cells.
Tatsumura T; Ariga T; Yu RK; Sartorelli AC
Cancer Res; 1988 Apr; 48(8):2121-4. PubMed ID: 3258184
[TBL] [Abstract][Full Text] [Related]
9. Favorable and unfavorable lateral interactions of ceramide, neutral glycosphingolipids and gangliosides in mixed monolayers.
Maggio B
Chem Phys Lipids; 2004 Dec; 132(2):209-24. PubMed ID: 15555606
[TBL] [Abstract][Full Text] [Related]
10. Structure elucidation of neutral, di-, tri-, and tetraglycosylceramides from High Five cells: identification of a novel (non-arthro-series) glycosphingolipid pathway.
Fuller MD; Schwientek T; Wandall HH; Pedersen JW; Clausen H; Levery SB
Glycobiology; 2005 Dec; 15(12):1286-301. PubMed ID: 16014747
[TBL] [Abstract][Full Text] [Related]
11. Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Tetsuka T; Motoyoshi K; Miura Y; Saito M
Blood; 1984 Aug; 64(2):534-41. PubMed ID: 6589019
[TBL] [Abstract][Full Text] [Related]
12. Glycosphingolipid expression in acute nonlymphocytic leukemia: common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts.
Cooling LL; Zhang DS; Naides SJ; Koerner TA
Blood; 2003 Jan; 101(2):711-21. PubMed ID: 12393713
[TBL] [Abstract][Full Text] [Related]
13. Analysis of breast cancer-associated glycosphingolipids using electrospray ionization-linear ion trap quadrupole mass spectrometry.
Zhu T; Xu L; Xu X; Wang Z; Zhu J; Xie Q; Zhang B; Wang Y; Ju L; He Y; Ye X; Zhou D; Li Y
Carbohydr Res; 2015 Jan; 402():189-99. PubMed ID: 25498019
[TBL] [Abstract][Full Text] [Related]
14. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
[TBL] [Abstract][Full Text] [Related]
15. Contents of total and protein-bound carbohydrates are low in leukemic leukocytes from patients with acute myelogenous leukemia.
Smoleńska-Sym G; Zdebska E; Gołaszewska E; Woźniak J; Durzyński T; Maj S; Mokras U; Kościelak J
Acta Biochim Pol; 1998; 45(2):361-71. PubMed ID: 9821867
[TBL] [Abstract][Full Text] [Related]
16. Clear differences in ceramide metabolism between glycosphingolipids and sphingomyelin in a human promyelocytic leukemia cell line HL-60 stimulated by a differentiation inducer.
Yokoyama K; Nojiri H; Suzuki M; Setaka M; Suzuki A; Nojima S
FEBS Lett; 1995 Jul; 368(3):477-80. PubMed ID: 7635202
[TBL] [Abstract][Full Text] [Related]
17. Conversion of short-chain ceramides to short-chain ceramide GM3 in B16 melanoma cells.
Komori H; Ito M
FEBS Lett; 1995 Oct; 374(2):299-302. PubMed ID: 7589558
[TBL] [Abstract][Full Text] [Related]
18. Glycosphingolipids regulate ameloblastin expression in dental epithelial cells.
Kamasaki Y; Nakamura T; Yoshizaki K; Iwamoto T; Yamada A; Fukumoto E; Maruya Y; Iwabuchi K; Furukawa K; Fujiwara T; Fukumoto S
J Dent Res; 2012 Jan; 91(1):78-83. PubMed ID: 21979133
[TBL] [Abstract][Full Text] [Related]
19. Partial characterization of glycosphingolipids of Agelas sponges in their peracetylated form by liquid secondary ionization mass spectrometry and high-performance liquid chromatography combined with direct electrospray ionization mass spectrometric detection.
Szilágyi Z; Pócsfalvi G; Costantino V; Mangoni A; Malorni A; Fattorusso E
Rapid Commun Mass Spectrom; 2004; 18(24):2989-96. PubMed ID: 15536635
[TBL] [Abstract][Full Text] [Related]
20. Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential.
Hanisch FG; Sölter J; Jansen V; Lochner A; Peter-Katalinic J; Uhlenbruck G
Br J Cancer; 1990 Jun; 61(6):813-20. PubMed ID: 2372482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
